What is Teradyne's free cash flow?

Latest reported free cash flow for Teradyne (TER) is $553.18M as of the trailing twelve months (TTM) ending March 29, 2026.

How has Teradyne free cash flow changed year-over-year?

Teradyne (TER) free cash flow changed -5.0% year-over-year on the latest annual filing.

What is the long-term growth rate of Teradyne free cash flow?

Teradyne (TER) free cash flow compound annual growth rate is -8.0% over the most recent 5 years available.

When did Teradyne free cash flow hit its highest annual value?

Teradyne free cash flow reached its highest annual value of $965.89M in 2021.

What was Teradyne free cash flow in 2024?

Teradyne (TER) free cash flow in 2024 was $474.08M.

What was Teradyne free cash flow in 2025?

Teradyne (TER) free cash flow in 2025 was $450.41M.

Teradyne (TER) Free Cash Flow

Latest period

$553.18M

YoY change

-5.0%

5Y CAGR

-8.0%

Peak year (2021)

$965.89M

Free Cash Flow history chart for Teradyne (TER) from 1989 to 2025

Latest: $450.41M

Free Cash Flow growth chart for Teradyne (TER) from 1989 to 2025

Latest: -5.0%

Free Cash Flow history table for Teradyne (TER) from 1989 to 2025


2025	$450.41M	-5.0%	−$23.68M	Dec 31, 2025	Feb 19, 2026
2024	$474.08M	+11.4%	+$48.49M	Dec 31, 2024	Feb 20, 2025
2023	$425.59M	+2.6%	+$10.91M	Dec 31, 2023	Feb 22, 2024
2022	$414.67M	-57.1%	−$551.22M	Dec 31, 2022	Feb 22, 2023
2021	$965.89M	+41.2%	+$281.94M	Dec 31, 2021	Feb 23, 2022
2020	$683.96M	+54.0%	+$239.85M	Dec 31, 2020	Feb 22, 2021
2019	$444.11M	+22.5%	+$81.61M	Dec 31, 2019	Mar 2, 2020
2018	$362.50M	-30.4%	−$158.62M	Dec 31, 2018	Mar 1, 2019
2017	$521.12M	+44.5%	+$160.59M	Dec 31, 2017	Mar 1, 2018
2016	$360.53M	+12.4%	+$39.82M	Dec 31, 2016	Mar 1, 2017
2015	$320.71M	-0.7%	−$2.37M	Dec 31, 2015	Feb 29, 2016
2014	$323.08M	+101.2%	+$162.54M	Dec 31, 2014	Feb 27, 2015
2013	$160.54M	-43.8%	−$124.91M	Dec 31, 2013	Feb 28, 2014
2012	$285.45M	+52.1%	+$97.78M	Dec 31, 2012	Mar 1, 2013
2011	$187.67M	-61.8%	−$303.09M	Dec 31, 2011	Feb 29, 2012
2010	$490.76M	+518.2%	+$411.37M	Dec 31, 2010	Mar 1, 2011
2009	$79.39M	+4.5%	+$3.45M	Dec 31, 2009	Mar 1, 2010
2008	$75.93M	+80.4%	+$33.83M	Dec 31, 2008	Mar 2, 2009
2007	$42.10M	-87.6%	−$297.57M	Dec 31, 2007	Feb 28, 2008
2006	$339.67M	-442.6%	+$438.82M	Dec 31, 2006	Mar 1, 2007
2005	−$99.15M	-198.9%	−$199.42M	Dec 31, 2005	Mar 14, 2006
2004	$100.27M	+2905.7%	+$96.93M	Dec 31, 2004	Mar 16, 2005
2003	$3.34M	-106.6%	+$54.02M	Dec 31, 2003	Mar 15, 2004
2002	−$50.68M	-81.7%	+$226.47M	Dec 31, 2002	Mar 28, 2003
2001	−$277.15M	-217.6%	−$512.82M	Dec 31, 2001	Mar 29, 2002
2000	$235.67M	-4.9%	−$12.03M	Dec 31, 2000	Mar 27, 2001
1999	$247.70M	+107.9%	+$128.53M	Dec 31, 1999	Mar 27, 2000
1998	$119.16M	-228.2%	+$212.15M	Dec 31, 1998	Mar 30, 1999
1997	−$92.98M	-148.6%	−$284.31M	Dec 31, 1997	Mar 30, 1998
1996	$191.33M	+426.5%	+$154.99M	Dec 31, 1996	Mar 27, 1997
1995	$36.34M	-44.0%	−$28.51M	Dec 31, 1995	Mar 26, 1996
1994	$64.85M	-9.0%	−$6.38M	Dec 31, 1994	Mar 23, 1995
1993	$71.23M	+236.0%	+$50.03M	Dec 31, 1993	Mar 31, 1994
1992	$21.20M	+19.8%	+$3.50M	Dec 31, 1992	Dec 31, 1992
1991	$17.70M	+34.1%	+$4.50M	Dec 31, 1991	Dec 31, 1991
1990	$13.20M	-10.2%	−$1.50M	Dec 31, 1990	Dec 31, 1990
1989	$14.70M	—	—	Dec 31, 1989	Dec 31, 1989

2025$450.41M-5.0%
2024$474.08M+11.4%
2023$425.59M+2.6%
2022$414.67M-57.1%
2021$965.89M+41.2%
2020$683.96M+54.0%
2019$444.11M+22.5%
2018$362.50M-30.4%
2017$521.12M+44.5%
2016$360.53M+12.4%
2015$320.71M-0.7%
2014$323.08M+101.2%
2013$160.54M-43.8%
2012$285.45M+52.1%
2011$187.67M-61.8%
2010$490.76M+518.2%
2009$79.39M+4.5%
2008$75.93M+80.4%
2007$42.10M-87.6%
2006$339.67M-442.6%
2005−$99.15M-198.9%
2004$100.27M+2905.7%
2003$3.34M-106.6%
2002−$50.68M-81.7%
2001−$277.15M-217.6%
2000$235.67M-4.9%
1999$247.70M+107.9%
1998$119.16M-228.2%
1997−$92.98M-148.6%
1996$191.33M+426.5%
1995$36.34M-44.0%
1994$64.85M-9.0%
1993$71.23M+236.0%
1992$21.20M+19.8%
1991$17.70M+34.1%
1990$13.20M-10.2%
1989$14.70M—

Free Cash Flow values are taken from Teradyne's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Free Cash Flow at Teradyne (TER)

Free Cash Flow for Teradyne (TER): headline value $553.18M · YoY -5.0%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending March 29, 2026 (reported May 1, 2026). Chart and table below cover the full reported history back to 1989.

2025's annual free cash flow for Teradyne (TER) came in at $450.41M – edged down 5.0% year-over-year.

Over 2020–2025 (5 years), Teradyne free cash flow expanded at a -8.0% compound annual rate, with a net decline across the window.

Between 2021 and 2025, Teradyne free cash flow plunged 53.4%, falling from $965.89M to $450.41M.

$965.89M stands as the all-time-high annual free cash flow, posted in 2021, against a low of −$277.15M during 2001.

Teradyne Free Cash Flow by Year

Teradyne Free Cash Flow 2025: $450.41M

Teradyne free cash flow in 2025 was $450.41M, edged down 5.0% below 2024.

Teradyne Free Cash Flow 2024: $474.08M

2024's free cash flow for Teradyne came in at $474.08M, grew 11.4% from 2023.

Teradyne Free Cash Flow 2023: $425.59M

Teradyne posted free cash flow of $425.59M in 2023, edged up 2.6% from 2022.

Teradyne Free Cash Flow 2022: $414.67M

In 2022, Teradyne reported free cash flow of $414.67M, plunged 57.1% below 2021.

Teradyne Free Cash Flow 2021: $965.89M

Teradyne free cash flow in 2021 was $965.89M.

See more financial history for Teradyne (TER).

Sector peers by Free Cash Flow

Technology peers of Teradyne (TER), ranked by their latest free cash flow


Apple (AAPL)	$98.77B
NVIDIA (NVDA)	$96.68B
Microsoft (MSFT)	$71.61B
TSMC (TSM)	$35.39B
Broadcom (AVGO)	$26.91B
ASML (ASML)	$12.40B
AMD (AMD)	$6.74B
Micron Technology (MU)	$1.67B

Frequently asked questions

Teradyne (TER) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation